精品文档---下载后可任意编辑ICD 适应证患者的调查和随访的开题报告Title: Survey and Follow-up of Patients with Indications for Implantable Cardioverter Defibrillator (ICD) TherapyIntroduction:Implantable Cardioverter Defibrillator (ICD) is a device that provides continuous monitoring of the heart rhythm and is designed to deliver an electrical shock to restore normal heart rhythm in case of life-threatening arrhythmias. ICD therapy is indicated for a variety of conditions such as primary prevention in patients with a history of heart attack or heart failure, as well as secondary prevention in patients with a history of cardiac arrest or sustained ventricular tachycardia. However, studies have reported that ICD therapy is underutilized among eligible patients, highlighting the need for better detection and management of patients with indications for ICD therapy.Objectives:The main objective of this study is to survey and follow-up patients with indications for ICD therapy, with specific aims including:1. To assess the awareness, knowledge, and perception of ICD therapy among eligible patients2. To evaluate the utilization of ICD therapy among eligible patients and identify factors affecting the utilization3. To determine the clinical outcomes and quality of life of patients who received ICD therapy4. To identify the challenges and barriers in the detection, referral, and management of patients with indications for ICD therapyMethods:This study will be conducted as a cross-sectional survey and a prospective follow-up study. The survey will be administered to eligible patients who meet the indications for ICD therapy at the participating healthcare centers. The survey will consist of multiple-choice questions and will assess the awareness, knowledge, and perception of ICD therapy, as well as factors affecting the utilization. For the follow-up study, 精品文档---下载后可任意编辑eligible patients who receive ICD therapy will be enrolled and followed up for 1 year. Clinical outcomes (including arrhythmia recurrence, hospitalization, and mortality) and quality of life will be assessed at baseline and at every follow-up visit. Factors affecting the outcomes will also be evaluated.Expected Results:This study is expected to provide valuable insights into the utilization, outcomes, and challenges of ICD therapy among eligible patients. The findings will be useful in improving the detection and management of patients with indications for ICD therapy, as well as in promoting the awareness and knowledge of ICD therapy among eligible patients. Ultimately, this study has the potential to improve the outcomes and quality of life of patients with life-threatening arrhythmias.
